Penumbra Stock Price, News & Analysis (NYSE:PEN)

$102.15 +2.55 (+2.56 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$102.15
Today's Range$98.60 - $102.25
52-Week Range$74.15 - $116.35
Volume115,507 shs
Average Volume187,071 shs
Market Capitalization$3.38 billion
P/E Ratio-464.32
Dividend YieldN/A
Beta0.19

About Penumbra (NYSE:PEN)

Penumbra logoPenumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.

Receive PEN News and Ratings via Email

Sign-up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment
Sub-IndustryN/A
SectorMedical
SymbolNYSE:PEN
CUSIPN/A
Phone510-748-3200

Debt

Debt-to-Equity RatioN/A
Current Ratio7.28%
Quick Ratio5.51%

Price-To-Earnings

Trailing P/E Ratio-464.318181818182
Forward P/E Ratio-729.64
P/E Growth117.18

Sales & Book Value

Annual Sales$263.32 million
Price / Sales13.17
Cash Flow$0.59 per share
Price / Cash174.09
Book Value$8.42 per share
Price / Book12.13

Profitability

Trailing EPS($0.22)
Net Income$14.81 million
Net Margins-2.19%
Return on Equity-1.95%
Return on Assets-1.70%

Miscellaneous

Employees1,500
Outstanding Shares33,940,000

Penumbra (NYSE:PEN) Frequently Asked Questions

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

How were Penumbra's earnings last quarter?

Penumbra Inc (NYSE:PEN) released its quarterly earnings data on Tuesday, November, 7th. The company reported $0.01 EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.07. The business earned $83.90 million during the quarter, compared to the consensus estimate of $79.17 million. Penumbra had a negative return on equity of 1.95% and a negative net margin of 2.19%. The firm's revenue was up 24.9% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.04) earnings per share. View Penumbra's Earnings History.

Where is Penumbra's stock going? Where will Penumbra's stock price be in 2018?

4 brokerages have issued twelve-month price targets for Penumbra's shares. Their forecasts range from $110.00 to $113.00. On average, they expect Penumbra's share price to reach $111.50 in the next twelve months. View Analyst Ratings for Penumbra.

Who are some of Penumbra's key competitors?

Who are Penumbra's key executives?

Penumbra's management team includes the folowing people:

  • Adam Elsesser, Chairman of the Board, President, Chief Executive Officer (Age 55)
  • Sridhar Kosaraju, Chief Financial Officer and Head of Strategy (Age 39)
  • Daniel Donen Davis, President, North America (Age 39)
  • James Pray, President, International (Age 53)
  • Robert D. Evans, Executive Vice President, General Counsel, Secretary (Age 70)
  • Lynn Rothman, Executive Vice President and Chief Business Officer (Age 56)
  • Arani Bose M.D., Executive Director and Chief Innovator (Age 55)
  • Harpreet S. Grewal, Independent Director (Age 50)
  • Don W. Kassing, Presiding Independent Director (Age 75)
  • Bridget O'Rourke, Independent Director (Age 49)

Who owns Penumbra stock?

Penumbra's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.71%), Alliancebernstein L.P. (3.56%), Redmile Group LLC (1.82%), Eagle Asset Management Inc. (1.63%), Champlain Investment Partners LLC (1.17%) and Carillon Tower Advisers Inc. (1.06%). Company insiders that own Penumbra stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Daniel Donen Davis, Don W Kassing, Harpreet Grewal, James Robert Pray, Lynn Rothman, Robert D Evans, Sridhar Kosaraju and Thomas Wilder. View Institutional Ownership Trends for Penumbra.

Who sold Penumbra stock? Who is selling Penumbra stock?

Penumbra's stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Allianz Asset Management GmbH, Champlain Investment Partners LLC, Frontier Capital Management Co. LLC, Nicholas Investment Partners LP, Wells Fargo & Company MN, Next Century Growth Investors LLC and Alliancebernstein L.P.. Company insiders that have sold Penumbra company stock in the last year include Adam Elsesser, Arani Bose, Bridget O'rourke, Daniel Donen Davis, Don W Kassing, Harpreet Grewal, James Robert Pray, Lynn Rothman, Robert D Evans, Sridhar Kosaraju and Thomas Wilder. View Insider Buying and Selling for Penumbra.

Who bought Penumbra stock? Who is buying Penumbra stock?

Penumbra's stock was purchased by a variety of institutional investors in the last quarter, including Carillon Tower Advisers Inc., Redmile Group LLC, Deutsche Bank AG, BlackRock Inc., Victory Capital Management Inc., MetLife Investment Advisors LLC, Kennedy Capital Management Inc. and Geode Capital Management LLC. View Insider Buying and Selling for Penumbra.

How do I buy Penumbra stock?

Shares of Penumbra can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Penumbra's stock price today?

One share of Penumbra stock can currently be purchased for approximately $102.15.

How big of a company is Penumbra?

Penumbra has a market capitalization of $3.38 billion and generates $263.32 million in revenue each year. The company earns $14.81 million in net income (profit) each year or ($0.22) on an earnings per share basis. Penumbra employs 1,500 workers across the globe.

How can I contact Penumbra?

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The company can be reached via phone at 510-748-3200 or via email at [email protected]


MarketBeat Community Rating for Penumbra (PEN)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  138 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  217
MarketBeat's community ratings are surveys of what our community members think about Penumbra and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Penumbra (NYSE:PEN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldBuyBuy
Consensus Rating Score: 2.502.333.003.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $111.50$111.50$115.00$98.00
Price Target Upside: 12.23% upside13.72% upside1.41% upside16.53% upside

Penumbra (NYSE:PEN) Consensus Price Target History

Price Target History for Penumbra (NYSE:PEN)

Penumbra (NYSE:PEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/21/2018William BlairInitiated CoverageOutperform -> OutperformLowView Rating Details
1/24/2018Canaccord GenuityReiterated RatingBuy$113.00MediumView Rating Details
1/2/2018JPMorgan Chase & Co.DowngradeOverweight -> NeutralHighView Rating Details
12/12/2017BMO Capital MarketsDowngradeOutperform -> Market Perform$117.00 -> $110.00HighView Rating Details
3/14/2016Wells Fargo & CoReiterated RatingOutperformN/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Penumbra (NYSE:PEN) Earnings History and Estimates Chart

Earnings by Quarter for Penumbra (NYSE:PEN)

Penumbra (NYSE PEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2017Q3 2017($0.06)$0.01$79.17 million$83.90 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.05)($0.05)$77.16 million$80.60 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.06)($0.10)$71.08 million$73.21 millionViewListenView Earnings Details
2/28/2017Q416($0.09)($0.08)$67.54 million$73.10 millionViewListenView Earnings Details
11/3/2016Q316($0.08)($0.04)$63.25 million$67.20 millionViewN/AView Earnings Details
8/9/2016Q216($0.07)$0.01$58.18 million$65.10 millionViewN/AView Earnings Details
5/9/2016Q116($0.07)$0.02$53.10 million$57.90 millionViewN/AView Earnings Details
3/8/2016Q415($0.10)$0.05$46.76 million$54.40 millionViewN/AView Earnings Details
11/12/2015Q315($0.15)$0.03$43.00 million$50.42 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Penumbra (NYSE:PEN) Earnings Estimates

2018 EPS Consensus Estimate: $0.03
2019 EPS Consensus Estimate: $0.22
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.02)($0.02)($0.02)
Q2 20181$0.01$0.01$0.01
Q3 20181$0.02$0.02$0.02
Q4 20181$0.02$0.02$0.02
Q1 20191$0.06$0.06$0.06
Q2 20191$0.06$0.06$0.06
Q3 20191$0.04$0.04$0.04
Q4 20191$0.06$0.06$0.06
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Penumbra (NYSE:PEN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Penumbra (NYSE PEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 13.50%
Institutional Ownership Percentage: 71.09%
Insider Trades by Quarter for Penumbra (NYSE:PEN)
Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Penumbra (NYSE PEN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018Don W KassingDirectorSell2,000$100.94$201,880.002,648View SEC Filing  
1/16/2018Daniel Donen DavisInsiderSell30,000$88.80$2,664,000.00View SEC Filing  
1/16/2018Lynn RothmanEVPSell6,000$90.99$545,940.00159,519View SEC Filing  
1/2/2018Robert D EvansEVPSell40,000$89.89$3,595,600.0011,704View SEC Filing  
1/2/2018Thomas WilderDirectorSell345$91.15$31,446.75View SEC Filing  
11/28/2017Adam ElsesserCEOSell10,000$103.95$1,039,500.001,121,356View SEC Filing  
11/28/2017Arani BoseInsiderSell10,927$103.96$1,135,970.92639,527View SEC Filing  
11/28/2017Sridhar KosarajuCFOSell6,026$103.83$625,679.58View SEC Filing  
11/24/2017Adam ElsesserCEOSell10,135$105.10$1,065,188.501,133,672View SEC Filing  
11/24/2017James Robert PrayInsiderSell5,088$105.26$535,562.88523,894View SEC Filing  
11/24/2017Sridhar KosarajuCFOSell4,818$105.10$506,371.80View SEC Filing  
11/22/2017Adam ElsesserCEOSell5,051$105.98$535,304.981,133,672View SEC Filing  
11/22/2017Arani BoseInsiderSell6,248$106.10$662,912.80652,118View SEC Filing  
11/22/2017Sridhar KosarajuCFOSell2,600$105.99$275,574.00View SEC Filing  
11/21/2017Bridget O'rourkeDirectorSell429$106.60$45,731.40View SEC Filing  
11/20/2017Adam ElsesserCEOSell62,862$105.15$6,609,939.301,191,887View SEC Filing  
11/20/2017Arani BoseInsiderSell47,136$105.15$4,956,350.40700,815View SEC Filing  
11/20/2017Sridhar KosarajuCFOSell21,956$105.27$2,311,308.12View SEC Filing  
11/17/2017Adam ElsesserCEOSell11,186$103.56$1,158,422.161,191,887View SEC Filing  
11/17/2017Arani BoseInsiderSell8,133$103.50$841,765.50700,815View SEC Filing  
11/17/2017Sridhar KosarajuCFOSell4,290$103.52$444,100.80View SEC Filing  
11/15/2017Adam ElsesserCEOSell24,444$105.83$2,586,908.521,231,338View SEC Filing  
11/15/2017Arani BoseInsiderSell16,452$105.89$1,742,102.28728,680View SEC Filing  
11/15/2017Sridhar KosarajuCFOSell10,900$105.89$1,154,201.00View SEC Filing  
10/5/2017Harpreet GrewalDirectorSell500$92.90$46,450.00View SEC Filing  
10/2/2017Thomas WilderDirectorSell345$90.20$31,119.00View SEC Filing  
9/29/2017Robert D EvansEVPSell20,017$90.03$1,802,130.5111,704View SEC Filing  
9/28/2017Robert D EvansEVPSell2,108$90.00$189,720.0011,704View SEC Filing  
9/27/2017Robert D EvansEVPSell1,586$90.00$142,740.0011,704View SEC Filing  
9/21/2017Robert D EvansEVPSell4,983$90.00$448,470.0011,704View SEC Filing  
9/20/2017Robert D EvansEVPSell2,859$90.00$257,310.0011,704View SEC Filing  
8/21/2017Harpreet GrewalDirectorSell4,500$82.65$371,925.00View SEC Filing  
8/9/2017Robert D EvansEVPSell10,000$85.15$851,500.0011,704View SEC Filing  
8/1/2017Daniel Donen DavisInsiderSell32,000$79.42$2,541,440.00View SEC Filing  
7/18/2017Thomas WilderDirectorSell345$86.10$29,704.50View SEC Filing  
4/24/2017Robert D EvansEVPSell10,000$85.24$852,400.0012,075View SEC Filing  
2/14/2017Robert D EvansEVPSell5,000$75.00$375,000.007,075View SEC Filing  
2/13/2017Adam ElsesserCEOSell7,700$72.21$556,017.001,241,938View SEC Filing  
2/13/2017James Robert PrayInsiderSell1,700$73.04$124,168.00543,778View SEC Filing  
2/13/2017Sridhar KosarajuCFOSell1,600$72.94$116,704.00View SEC Filing  
2/10/2017James Robert PrayInsiderSell23,900$71.08$1,698,812.00566,978View SEC Filing  
2/10/2017Sridhar KosarajuCFOSell15,500$71.49$1,108,095.00View SEC Filing  
2/9/2017Arani BoseInsiderSell22,300$70.44$1,570,812.00736,191View SEC Filing  
2/9/2017Lynn RothmanEVPSell2,700$70.20$189,540.00View SEC Filing  
2/7/2017James Robert PrayInsiderSell4,099$69.09$283,199.91575,178View SEC Filing  
2/7/2017Robert D EvansEVPSell1$70.00$70.007,075View SEC Filing  
2/6/2017Arani BoseInsiderSell17,100$70.01$1,197,171.00736,691View SEC Filing  
2/6/2017Lynn RothmanEVPSell2,886$70.41$203,203.26View SEC Filing  
2/6/2017Sridhar KosarajuCFOSell100$70.00$7,000.00View SEC Filing  
2/3/2017James Robert PrayInsiderSell15,600$70.39$1,098,084.00590,159View SEC Filing  
2/3/2017Robert D EvansEVPSell5,000$70.35$351,750.007,075View SEC Filing  
2/3/2017Sridhar KosarajuCFOSell7,800$70.56$550,368.00View SEC Filing  
2/1/2017Adam ElsesserCEOSell21,400$70.98$1,518,972.001,244,038View SEC Filing  
2/1/2017Daniel Donen DavisInsiderSell7,298$71.00$518,158.00View SEC Filing  
2/1/2017Lynn RothmanEVPSell4,414$70.99$313,349.86View SEC Filing  
1/31/2017Adam ElsesserCEOSell9,000$71.26$641,340.001,244,038View SEC Filing  
1/31/2017Daniel Donen DavisInsiderSell3,000$71.29$213,870.00View SEC Filing  
1/31/2017Lynn RothmanEVPSell1,800$71.27$128,286.00View SEC Filing  
1/30/2017Adam ElsesserCEOSell8,200$70.72$579,904.001,244,038View SEC Filing  
1/30/2017Daniel Donen DavisInsiderSell2,698$70.71$190,775.58View SEC Filing  
1/30/2017Lynn RothmanEVPSell1,700$70.79$120,343.00View SEC Filing  
1/27/2017Arani BoseInsiderSell31,500$74.12$2,334,780.00748,691View SEC Filing  
1/27/2017Lynn RothmanEVPSell7,000$74.24$519,680.00View SEC Filing  
1/26/2017Don W KassingDirectorSell3,000$74.50$223,500.002,666View SEC Filing  
11/16/2016Sridhar KosarajuCFOSell25,000$65.07$1,626,750.00View SEC Filing  
9/9/2016Adam ElsesserCEOSell57,200$71.07$4,065,204.001,249,838View SEC Filing  
9/6/2016Arani BoseInsiderSell61,000$70.72$4,313,920.00742,891View SEC Filing  
9/2/2016Robert D EvansEVPSell3,100$70.10$217,310.002,538View SEC Filing  
8/31/2016Adam ElsesserCEOSell26,000$71.15$1,849,900.001,244,838View SEC Filing  
8/31/2016Robert D EvansEVPSell5,300$71.17$377,201.002,538View SEC Filing  
8/26/2016Adam ElsesserCEOSell26,800$71.06$1,904,408.001,244,638View SEC Filing  
8/26/2016Robert D EvansEVPSell5,300$71.03$376,459.002,538View SEC Filing  
8/24/2016Adam ElsesserCEOSell29,000$72.95$2,115,550.001,245,938View SEC Filing  
8/24/2016Robert D EvansEVPSell6,300$73.00$459,900.002,538View SEC Filing  
5/23/2016Robert D EvansEVPSell5,000$50.52$252,600.002,538View SEC Filing  
5/19/2016Don W KassingDirectorSell3,000$48.63$145,890.004,000View SEC Filing  
5/19/2016Robert D EvansEVPBuy1,538$25.50$39,219.002,538View SEC Filing  
5/16/2016James Robert PrayInsiderSell32,500$48.51$1,576,575.00631,770View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Penumbra (NYSE PEN) News Headlines

Source:
DateHeadline
Is Penumbra Inc (NYSE:PEN) An Industry Laggard Or Leader?Is Penumbra Inc (NYSE:PEN) An Industry Laggard Or Leader?
finance.yahoo.com - February 23 at 9:10 AM
William Blair Comments on Penumbra Incs FY2017 Earnings (PEN)William Blair Comments on Penumbra Inc's FY2017 Earnings (PEN)
www.americanbankingnews.com - February 23 at 8:24 AM
Penumbra Has Challenged The Paradigm Of Stroke Treatment; William Blair Initiates At OutperformPenumbra Has Challenged The 'Paradigm' Of Stroke Treatment; William Blair Initiates At Outperform
finance.yahoo.com - February 22 at 9:06 AM
Afghan tradition helps strangers become friends over dinnerAfghan tradition helps strangers become friends over dinner
www.msn.com - February 21 at 4:50 PM
Penumbra Inc (PEN) Given Average Recommendation of "Hold" by BrokeragesPenumbra Inc (PEN) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 21 at 11:18 AM
Penumbra (PEN) Research Coverage Started at William BlairPenumbra (PEN) Research Coverage Started at William Blair
www.americanbankingnews.com - February 21 at 10:58 AM
Key Factors to Influence Penumbra's (PEN) Earnings in Q4Key Factors to Influence Penumbra's (PEN) Earnings in Q4
finance.yahoo.com - February 21 at 9:15 AM
Penumbra Inc (PEN) Expected to Post Earnings of -$0.01 Per SharePenumbra Inc (PEN) Expected to Post Earnings of -$0.01 Per Share
www.americanbankingnews.com - February 19 at 1:16 AM
Should You Buy Penumbra Inc (NYSE:PEN) At $93.6?Should You Buy Penumbra Inc (NYSE:PEN) At $93.6?
finance.yahoo.com - February 15 at 4:44 PM
Penumbra Inc (PEN) Expected to Post Quarterly Sales of $87.80 MillionPenumbra Inc (PEN) Expected to Post Quarterly Sales of $87.80 Million
www.americanbankingnews.com - February 4 at 11:40 AM
-$0.01 Earnings Per Share Expected for Penumbra Inc (PEN) This Quarter-$0.01 Earnings Per Share Expected for Penumbra Inc (PEN) This Quarter
www.americanbankingnews.com - February 2 at 1:18 AM
Analysts Anticipate Penumbra Inc (PEN) to Announce ($0.01) Earnings Per ShareAnalysts Anticipate Penumbra Inc (PEN) to Announce ($0.01) Earnings Per Share
www.americanbankingnews.com - February 1 at 11:54 AM
Insider Selling: Penumbra Inc (PEN) Director Sells 2,000 Shares of StockInsider Selling: Penumbra Inc (PEN) Director Sells 2,000 Shares of Stock
www.americanbankingnews.com - January 31 at 9:26 PM
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018 at 5:00 PM Eastern TimePenumbra, Inc. Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018 at 5:00 PM Eastern Time
finance.yahoo.com - January 30 at 4:18 PM
Should You Be Concerned About Penumbra Inc’s (NYSE:PEN) Investors?Should You Be Concerned About Penumbra Inc’s (NYSE:PEN) Investors?
finance.yahoo.com - January 30 at 9:47 AM
Aspiration First Approach with Penumbra System Demonstrates Favorable Outcomes for Acute Ischemic StrokeAspiration First Approach with Penumbra System Demonstrates Favorable Outcomes for Acute Ischemic Stroke
finance.yahoo.com - January 25 at 9:18 AM
Penumbra (PEN) Stock Rating Reaffirmed by Canaccord GenuityPenumbra (PEN) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - January 24 at 8:34 PM
Lynn Rothman Sells 6,000 Shares of Penumbra Inc (PEN) StockLynn Rothman Sells 6,000 Shares of Penumbra Inc (PEN) Stock
www.americanbankingnews.com - January 18 at 7:00 PM
Daniel Donen Davis Sells 30,000 Shares of Penumbra Inc (PEN) StockDaniel Donen Davis Sells 30,000 Shares of Penumbra Inc (PEN) Stock
www.americanbankingnews.com - January 18 at 6:34 PM
$87.80 Million in Sales Expected for Penumbra Inc (PEN) This Quarter$87.80 Million in Sales Expected for Penumbra Inc (PEN) This Quarter
www.americanbankingnews.com - January 18 at 12:04 PM
Penumbra (PEN) Raised to Hold at Zacks Investment ResearchPenumbra (PEN) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - January 17 at 11:26 AM
Penumbra Announces Key Events at International Stroke Conference 2018 MeetingPenumbra Announces Key Events at International Stroke Conference 2018 Meeting
finance.yahoo.com - January 17 at 10:11 AM
 Brokerages Set $113.60 Price Target for Penumbra Inc (PEN) Brokerages Set $113.60 Price Target for Penumbra Inc (PEN)
www.americanbankingnews.com - January 10 at 5:30 PM
Is Penumbra Inc (NYSE:PEN) As Financially Strong As Its Balance Sheet Indicates?Is Penumbra Inc (NYSE:PEN) As Financially Strong As Its Balance Sheet Indicates?
finance.yahoo.com - January 10 at 10:21 AM
Penumbra Inc (PEN) Director Sells $31,446.75 in StockPenumbra Inc (PEN) Director Sells $31,446.75 in Stock
www.americanbankingnews.com - January 4 at 9:50 PM
Penumbra Inc (PEN) EVP Sells $3,595,600.00 in StockPenumbra Inc (PEN) EVP Sells $3,595,600.00 in Stock
www.americanbankingnews.com - January 4 at 9:28 PM
Penumbra Announces the Formation of Joint Venture, MVI HealthPenumbra Announces the Formation of Joint Venture, MVI Health
finance.yahoo.com - January 4 at 10:11 AM
Brokerages Expect Penumbra Inc (PEN) to Announce ($0.01) Earnings Per ShareBrokerages Expect Penumbra Inc (PEN) to Announce ($0.01) Earnings Per Share
www.americanbankingnews.com - January 3 at 5:56 AM
JPMorgan Chase & Co. Lowers Penumbra (PEN) to NeutralJPMorgan Chase & Co. Lowers Penumbra (PEN) to Neutral
www.americanbankingnews.com - January 2 at 7:34 AM
Penumbra Inc (PEN) Expected to Announce Quarterly Sales of $87.80 MillionPenumbra Inc (PEN) Expected to Announce Quarterly Sales of $87.80 Million
www.americanbankingnews.com - January 1 at 4:38 PM
Penumbra Inc (PEN) Expected to Announce Earnings of -$0.01 Per SharePenumbra Inc (PEN) Expected to Announce Earnings of -$0.01 Per Share
www.americanbankingnews.com - December 30 at 7:50 AM
Stocks Flashing Renewed Technical Strength: PenumbraStocks Flashing Renewed Technical Strength: Penumbra
finance.yahoo.com - December 27 at 2:17 PM
Stocks Showing Improving Market Leadership: Penumbra Earns 83 RS RatingStocks Showing Improving Market Leadership: Penumbra Earns 83 RS Rating
finance.yahoo.com - December 21 at 4:41 PM
Penumbra, Inc. to Present at the 36th Annual J.P. Morgan Healthcare ConferencePenumbra, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 21 at 4:41 PM
ETFs with exposure to Penumbra, Inc. : December 21, 2017ETFs with exposure to Penumbra, Inc. : December 21, 2017
finance.yahoo.com - December 21 at 4:41 PM
Cramer says 'broken stock' Penumbra is giving investors a...Cramer says 'broken stock' Penumbra is giving investors a...
finance.yahoo.com - December 20 at 10:21 AM
Cramer says medical-device maker Penumbra is a 'broken st...Cramer says medical-device maker Penumbra is a 'broken st...
finance.yahoo.com - December 20 at 10:21 AM
 Penumbra Inc (PEN) Given $115.00 Consensus Target Price by Analysts Penumbra Inc (PEN) Given $115.00 Consensus Target Price by Analysts
www.americanbankingnews.com - December 19 at 3:52 PM
BMO Capital Markets Lowers Penumbra (PEN) to Market PerformBMO Capital Markets Lowers Penumbra (PEN) to Market Perform
www.americanbankingnews.com - December 17 at 10:44 PM
 Penumbra Inc (PEN) Receives Consensus Recommendation of "Strong Buy" from Analysts Penumbra Inc (PEN) Receives Consensus Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - December 15 at 7:38 PM
Was Penumbra Inc’s (NYSE:PEN) EPS Decline A Part Of Broader Industry Downturn?Was Penumbra Inc’s (NYSE:PEN) EPS Decline A Part Of Broader Industry Downturn?
finance.yahoo.com - December 15 at 4:54 PM
After Recent Run, Penumbra Downgraded On Fears Its Upside Is ExhaustedAfter Recent Run, Penumbra Downgraded On Fears Its Upside Is Exhausted
finance.yahoo.com - December 13 at 10:38 AM
Penumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : December 6, 2017Penumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : December 6, 2017
finance.yahoo.com - December 6 at 10:33 AM
Form 4 Penumbra Inc For: Nov 27 Filed by: Pray James RobertForm 4 Penumbra Inc For: Nov 27 Filed by: Pray James Robert
www.streetinsider.com - December 1 at 5:34 PM
Arani Bose Sells 10,927 Shares of Penumbra, Inc. (PEN) StockArani Bose Sells 10,927 Shares of Penumbra, Inc. (PEN) Stock
www.americanbankingnews.com - November 29 at 10:40 PM
Insider Selling: Penumbra, Inc. (PEN) CFO Sells 6,026 Shares of StockInsider Selling: Penumbra, Inc. (PEN) CFO Sells 6,026 Shares of Stock
www.americanbankingnews.com - November 29 at 10:40 PM
Insider Selling: Penumbra, Inc. (PEN) CEO Sells 10,000 Shares of StockInsider Selling: Penumbra, Inc. (PEN) CEO Sells 10,000 Shares of Stock
www.americanbankingnews.com - November 29 at 10:38 PM
Form 4 Penumbra Inc For: Nov 22 Filed by: Elsesser AdamForm 4 Penumbra Inc For: Nov 22 Filed by: Elsesser Adam
www.streetinsider.com - November 28 at 10:34 AM
Adam Elsesser Sells 5,051 Shares of Penumbra, Inc. (PEN) StockAdam Elsesser Sells 5,051 Shares of Penumbra, Inc. (PEN) Stock
www.americanbankingnews.com - November 27 at 10:28 PM
Arani Bose Sells 6,248 Shares of Penumbra, Inc. (PEN) StockArani Bose Sells 6,248 Shares of Penumbra, Inc. (PEN) Stock
www.americanbankingnews.com - November 27 at 10:28 PM

SEC Filings

Penumbra (NYSE:PEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Penumbra (NYSE:PEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Penumbra (NYSE PEN) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.